WiseGuyReports.com adds “Peptide Therapeutics Global Market 2016 to 2020” to its research database.
This market research report includes a detailed segmentation of the global peptide therapeutics market by route of administration (parenteral, oral, pulmonary, and mucosal), by drug class (somatostatins, vasopressin, calcitonin, LHRH, glucagon and analogs, and insulins), and by synthesis technology (liquid-phase peptide synthesis, solid-phase peptide synthesis, and hybrid peptide synthesis). The top vendors analyzed in this report are Eli Lilly, Novo Nordisk, Sanofi, Takeda, and Teva.
Outlook of the global peptide therapeutics market
Technavio’s market research analyst predicts the global peptide therapeutics market to grow steadily at a CAGR of around 8% during the forecast period. Recent advances in peptide synthesis technology will be the key driver for the growth of this market. Among all the methods of peptide synthesis, chemical and enzymatic syntheses are the most important. The synthesis of peptides has integrated structure-activity relationships (SARs) and analog generations to increase bioavailability, reduce adverse effects, increase the safety and efficacy of drugs, impart protease resistance, and develop formulations.
The recent shift towards untapped markets is another critical factor that will impel market growth during the forecast period. Recently, it has been observed that vendors of peptide therapeutics are moving to developing economies due to the presence of large population groups and clinical trial subjects. Factors such as the presence of lenient regulatory guidelines, low manufacturing costs, skilled labor, and limited market competition will compel vendors to shift their manufacturing processes to the developing countries.
Complete report in Detailed @ https://www.wiseguyreports.com/reports/global-peptide-therapeutics-market-2016-2020
Segmentation by route of administration and analysis of the peptide therapeutics market
In this market research, analysts have estimated the parenteral segment to be the largest market segment during the forecast period. At present, this segment dominates the market and is envisaged to retain its hold over the market until 2020 owing to factors like the higher bioavailability of drugs. Since the drugs administered through this route are absorbed quickly, it will result in the faster onset of action compared to other routes.
Order a Purchase Report Copy @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=366377
Geographical segmentation of the peptide therapeutics market
In terms of geography, the Americas dominated this market and is anticipated to grow at a CAGR of around 7% during the forecast period. Factors such as the recent rise in the incidence of cancer, hepatitis, and metabolic disorders, advances in peptide synthesis technology, and the augmented consumption of various peptide therapies are the primary growth drivers for the market in this region.
Competitive landscape and key vendors
The global peptide therapeutics market is highly fragmented because of the presence of numerous small and large vendors. The vendors in the market compete on the basis of price, quality, and innovation. The high level of competition among the vendors has led to an increase in the number of M&As; wherein smaller entities are being acquired by or are being merged with, major players.
The leading vendors in the market are -
- Eli Lilly
- Novo Nordisk
Other prominent vendors in the market include Abbvie,Advanced Accelerator Applications, Akashi Therapeutics, Amgen, Anthera Pharmaceuticals, AstraZeneca, Bachem, Bristol-Myers Squibb, Cardiorentis, CordenPharma International, Debiopharm, Derma Sciences, GlaxoSmithKline, Hanmi Pharmaceutical, Insmed, Ipsen, Johnson & Johnson, Lonza, Mallinckrodt, MolMed, Merck, Novartis, Nymox Pharmaceutical, Par Pharmaceuticals, PeptiDream, Polypeptide Group, Radius Health, Repligen, Roche, SciClone, Shire, The Medicines Company, Transition Therapeutics, X-Gen Pharmaceuticals, Zealand Pharma, and Zydus Cadila.
Enquiry before buying https://www.wiseguyreports.com/enquiry/global-peptide-therapeutics-market-2016-2020
P: +44 208 133 9349
M: +1 646 845 9349